Back
Enphase Energy Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
44
ENPH
Enphase Energy
Last Price:
114.95
Seasonality Move:
17.35%
Sell
36
SRPT
Sarepta Therapeutics
Last Price:
124.65
Seasonality Move:
-1.39%
Sell
44
Enphase Energy (ENPH)
is a Sell
Is Enphase Energy a Buy, Sell or Hold?
- The current Enphase Energy [ENPH] share price is $115.00. The Score for ENPH is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- ENPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ENPH Stock Price Chart
What is Enphase Energy's stock price today?
-
The Enphase Energy share price today is $115.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ENPH is experiencing slight selling pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $124.53
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.
ENPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.42 | Buy |
Relative Strength Index (14 RSI): | 51.33 | Buy |
Chaikin Money Flow: | -904742 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (109.13 - 120.67) | Buy |
Bollinger Bands (100): | (105.49 - 123.15) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.18 | Sell |
Relative Strength Index (14 RSI): | 35.54 | Sell |
Chaikin Money Flow: | -49995 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (124.27 - 135.95) | Sell |
Bollinger Bands (100): | (123.89 - 147.49) | Sell |
ENPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 115.95 | Sell |
20-day SMA: | 112.97 | Buy |
50-day SMA: | 113.12 | Buy |
200-day SMA: | 115.7 | Sell |
8-day EMA: | 114.74 | Buy |
20-day EMA: | 114.27 | Buy |
50-day EMA: | 113.74 | Buy |
200-day EMA: | 118.87 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 125.45 | Sell |
20-day SMA: | 127.75 | Sell |
50-day SMA: | 135.2 | Sell |
200-day SMA: | 127.53 | Sell |
8-day EMA: | 125.39 | Sell |
20-day EMA: | 128.04 | Sell |
50-day EMA: | 132.59 | Sell |
200-day EMA: | 128.64 | Sell |
Enphase Energy Earnings Growth & ENPH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.21 per share, an increase next quarter of $0.48 per share, a decrease this year of $1.83 per share, and an increase next year of $2.22 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.
Enphase Energy Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |